TP53 and breast carcinoma: To define a sublethal irradiation dose, we carried out a survival assay during which we tested the effect of 55, 100 and 200 J/m2 of UVB irradiation on the DNA damage response proficient MCF7 human breast cancer cell line, containing wild type p53 (Figure S1, and see below).